Paratek Pharmaceuticals, Inc. Annual Interest Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2022.
  • Paratek Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $5.29M, a 16.3% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $18.9M, a 6.05% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2022 was $18.1M, a 4.08% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2021 was $17.4M, a 14% decline from 2020.
  • Paratek Pharmaceuticals, Inc. annual Interest Expense for 2020 was $20.2M, a 23.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $18.1M +$711K +4.08% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $17.4M -$2.83M -14% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $20.2M +$3.84M +23.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $16.4M +$5.42M +49.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $11M +$5.91M +116% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $5.08M +$1.86M +57.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $3.22M +$2.45M +319% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-06
2015 $770K +$52K +7.24% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $718K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2011 $9K -$3K -25% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-30
2010 $12K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.